Nipple Discharge: When to See a Doctor

What Is Nipple Discharge and Is It Ever Normal?

Nipple discharge refers to any fluid that leaks from one or both nipples, either spontaneously or only when the nipple is squeezed. Discharge expressed only by firm bilateral compression in a person who has been pregnant within the past year is almost always physiologic. Spontaneous, unilateral, or blood-stained discharge is a different clinical picture and deserves investigation.

Physiologic vs. Pathological Discharge

Physiologic discharge typically has all of the following features: it comes from multiple ducts, it is bilateral, it requires manual expression, and it is milky or cloudy in color. Prolactin drives most physiologic milk production. A 2019 review in the British Medical Journal outlined that bilateral milky discharge in a non-pregnant, non-lactating person usually reflects hyperprolactinemia, which is itself caused by medications or a pituitary adenoma rather than primary breast pathology [1].

Pathological discharge is more likely when any one of these features is present: spontaneous leakage without squeezing, origin from a single duct opening, unilateral production, or a bloody or clear watery appearance. These features shift the pre-test probability toward structural causes including intraductal papilloma, duct ectasia, or malignancy.

How Common Is It?

Nipple discharge accounts for roughly 3-5% of breast-related office visits in the United States [2]. Among women who undergo surgery for pathological discharge, intraductal papilloma is the final pathology in approximately 35-48% of cases, duct ectasia in 15-20%, and carcinoma (ductal carcinoma in situ or invasive) in 5-15% [3].

What Causes Nipple Discharge?

The cause depends almost entirely on whether the discharge is physiologic or pathological, and on which specific features the discharge has. A structured look at each major category helps clarify the workup.

Hormonal and Medication-Related Causes

Galactorrhea (milky discharge unrelated to pregnancy or breastfeeding) is most often driven by elevated prolactin. Drugs that block dopamine receptors raise prolactin reliably: antipsychotics such as haloperidol and risperidone, antiemetics such as metoclopramide, and certain antidepressants including some SSRIs. A 2021 case series published in Endocrinology found that discontinuing the offending medication resolved galactorrhea in 78% of patients within 3 months without additional pharmacologic therapy [4].

Hypothyroidism can also raise prolactin indirectly. TRH (thyrotropin-releasing hormone) stimulates both TSH and prolactin secretion, so uncontrolled hypothyroidism occasionally presents with milky nipple discharge as its first visible symptom.

Structural Breast Causes

Intraductal papilloma. A small benign wart-like growth inside a milk duct. It produces serous or serosanguineous discharge, usually from one duct opening. Papillomas are the single most common cause of pathological discharge in women aged 30-50 [3].

Mammary duct ectasia. Widening and inflammation of the subareolar ducts. Discharge is typically thick, green-gray, or cheesy. It is more common in women approaching menopause and is generally benign, though the associated periductal inflammation can cause nipple retraction that mimics malignancy on examination.

Breast abscess or mastitis. Infection of the breast tissue produces purulent discharge and is accompanied by localized warmth, redness, and pain. Lactational mastitis affects roughly 10% of breastfeeding women [5]. Non-lactational mastitis is less common and more likely to involve unusual organisms such as anaerobes.

Pituitary Adenoma

Prolactinoma is the most common pituitary tumor, comprising about 40% of all pituitary adenomas [6]. Microadenomas (diameter <10 mm) often present with galactorrhea and menstrual irregularity in women, or with decreased libido and headache in men. Macroprolactinomas (>10 mm) may additionally produce visual field defects from optic chiasm compression. Serum prolactin levels above 200 ng/mL are strongly associated with macroprolactinoma, while levels of 25-200 ng/mL have a broader differential.

Malignancy

Breast cancer accounts for approximately 5-15% of pathological nipple discharge cases, most often ductal carcinoma in situ [3]. Features that raise concern for malignancy include age over 40, unilateral discharge from a single duct, a spontaneous rather than expressed pattern, a bloody or clear watery character, and any associated palpable mass. A 2020 study in JAMA Surgery noted that adding ductoscopy to standard imaging improved malignancy detection sensitivity from 67% to 84% in patients with unilateral spontaneous bloody discharge [7].

When Should You See a Doctor for Nipple Discharge?

See a clinician within 1-2 weeks if any of the following apply. Do not wait for a routine annual visit.

High-Priority Warning Signs

• The discharge is bloody, rust-colored, or appears clear and watery.
• The discharge comes from only one breast or one duct opening.
• The discharge occurs without any squeezing or stimulation.
• You have a palpable breast lump, skin dimpling, or nipple retraction alongside the discharge.
• You are a man with any nipple discharge (gynecomastia is common, but discharge in men has a higher relative risk of malignancy than in women) [8].

Situations That Are Likely Benign But Still Worth Checking

Milky bilateral discharge that began shortly after starting a new medication, or within 12 months of stopping breastfeeding, is almost always physiologic. Still, a single office visit to measure serum prolactin and TSH will either confirm benign physiology or catch a prolactinoma before it grows to a symptomatic size.

The American College of Obstetricians and Gynecologists (ACOG) states in its guidance on breast concerns: "Any nipple discharge that is spontaneous, unilateral, or bloody should be evaluated promptly with clinical breast examination and appropriate imaging" [9].

How Is Nipple Discharge Diagnosed?

A complete workup typically combines history, physical examination, blood tests, and imaging, with biopsy reserved for cases where imaging is suspicious or indeterminate.

Clinical History and Physical Examination

The clinician will ask about discharge color, whether it occurs spontaneously or only with expression, laterality, the number of duct openings involved, any associated symptoms (headache, vision changes, menstrual irregularity), and a full medication list. On examination, the breast is systematically palpated to identify the duct producing discharge, and the discharge is assessed for color and guaiac (blood) positivity.

Blood Tests

• Serum prolactin. Drawn in the morning, fasting, after 30 minutes of quiet rest. A single mildly elevated result should be repeated before concluding hyperprolactinemia is present. Levels above 200 ng/mL on two separate draws are diagnostic of prolactinoma until proven otherwise [6].
• TSH and free T4. Rules out hypothyroidism as a secondary driver of elevated prolactin.
• Beta-hCG. Pregnancy remains the most common cause of galactorrhea worldwide and should be excluded early.
• LH, FSH, estradiol or testosterone. Ordered when hypopituitarism is suspected alongside the discharge.

Imaging

For patients aged 30 and older, the ACR recommends diagnostic mammography plus targeted breast ultrasound as the first-line imaging combination [10]. For patients under 30, targeted ultrasound alone is preferred because breast density limits mammographic sensitivity in younger tissue.

MRI of the breasts may be added when ultrasound and mammography are both negative but clinical suspicion for malignancy remains high. Pituitary MRI with gadolinium contrast is ordered when serum prolactin is elevated to localize a potential adenoma.

Ductoscopy and Duct Excision

When imaging is negative but discharge persists, microductoscopy allows direct visualization of the duct lumen with a 0.9 mm fiber-optic scope. As noted above, ductoscopy improved malignancy detection sensitivity to 84% in one 2020 JAMA Surgery cohort [7]. Terminal duct lobular unit excision (microdochectomy) is both diagnostic and therapeutic for persistent pathological discharge from a single duct when other workup is inconclusive.

Cytology

Nipple discharge cytology has a sensitivity of only approximately 40-60% for malignancy and a high false-negative rate [11]. The American Society of Breast Surgeons does not recommend cytology as a standalone test to rule out cancer; imaging and, where indicated, tissue sampling are the standard.

Treatment Options for Nipple Discharge

Treatment is aimed at the underlying cause. There is no single "nipple discharge medication" because the appropriate therapy differs completely based on etiology.

Stopping or Switching the Causative Medication

When a dopamine-blocking drug is responsible for galactorrhea, working with the prescribing clinician to substitute a prolactin-neutral agent is the simplest fix. Quetiapine and aripiprazole have lower prolactin-raising effects than risperidone or olanzapine [4]. Discharge typically resolves within 3 months of the switch.

Treating Hyperprolactinemia and Prolactinoma

Dopamine agonists are first-line therapy for symptomatic prolactinoma. Cabergoline (0.5 mg twice weekly, titrated to response) normalizes prolactin in approximately 85% of patients and reduces tumor size in up to 80% of macroprolactinomas within 6-12 months, based on data from a landmark Italian multicenter study of 455 patients [12]. Bromocriptine is an older alternative with a higher side-effect burden.

Surgery (transsphenoidal adenomectomy) is reserved for patients who cannot tolerate dopamine agonists, who have progressive visual loss, or whose tumor fails to shrink after 12 months of medical therapy.

Treating Hypothyroidism

Levothyroxine replacement at adequate doses normalizes TSH and TSH-driven prolactin elevation. Galactorrhea resolves as euthyroidism is restored, usually within 2-4 months.

Surgical Management of Intraductal Papilloma and Duct Ectasia

A single benign papilloma confirmed by core needle biopsy may be managed by surgical excision (microdochectomy) to prevent recurrence, relieve symptoms, and obtain definitive pathology. Central duct excision is the preferred approach for duct ectasia causing significant or recurrent discharge. Both procedures are typically performed under local anesthesia as outpatient surgery.

Antibiotics for Mastitis and Breast Abscess

Lactational mastitis is treated with dicloxacillin 500 mg four times daily or cephalexin 500 mg four times daily for 10-14 days, with continued breastfeeding or pumping to prevent stasis [5]. A fluctuant abscess requires ultrasound-guided needle aspiration or incision and drainage.

When Malignancy Is Found

Management follows standard breast oncology protocols: surgery (lumpectomy or mastectomy depending on tumor extent), sentinel lymph node biopsy, and adjuvant therapy guided by tumor receptor status and staging. Hormone receptor-positive DCIS, the most common malignancy found behind pathological discharge, is treated with tamoxifen or aromatase inhibitors for 5 years after surgery to reduce recurrence risk.

Nipple Discharge in Special Populations

Men

Male nipple discharge is uncommon and has a higher relative rate of underlying malignancy than in women [8]. Male breast cancer accounts for roughly 1% of all breast cancers in the US, but any male patient with spontaneous, unilateral, or bloody nipple discharge should receive expedited imaging and referral.

Pregnancy and the Postpartum Period

Colostrum can appear as early as the second trimester. Clear or milky discharge during pregnancy is physiologic. Bloody discharge during pregnancy is less common and should be evaluated to rule out pregnancy-associated breast cancer, which, while rare, carries a worse prognosis when diagnosis is delayed [13].

Adolescents

Galactorrhea in adolescents most often reflects physiologic hormonal fluctuation or medication use. However, prolactinoma occurs in adolescents at a rate sufficient to justify serum prolactin measurement for any persistent discharge [6].

An Original Clinical Decision Framework for Nipple Discharge Evaluation

The following step-by-step approach consolidates ACR imaging criteria, Endocrine Society prolactin guidelines, and the American Society of Breast Surgeons recommendations into a single triage pathway for clinicians managing nipple discharge in outpatient settings.

Step 1. Characterize the discharge (5 minutes at the visit). Determine: spontaneous vs. Expressed only, unilateral vs. Bilateral, single duct vs. Multiple ducts, color, and blood positivity by guaiac test.

Step 2. Check the medication list first. If a known prolactin-raising drug is on the list and discharge is bilateral, milky, and expressed-only, a medication trial (switch or dose reduction in collaboration with the prescriber) plus serum prolactin and TSH is a reasonable starting point before imaging.

Step 3. Apply the imaging decision.

• Age <30 with non-bloody expressed bilateral discharge and no mass: serum prolactin, TSH, beta-hCG. Image only if labs are abnormal or discharge persists at 6-week follow-up.
• Age 30 or older OR any spontaneous, unilateral, or bloody discharge at any age: diagnostic mammogram plus targeted ultrasound at the same visit.

Step 4. Interpret imaging and triage accordingly.

• ACR BI-RADS 1 or 2 with benign clinical picture: reassure and follow up in 6 months.
• ACR BI-RADS 3: short-interval follow-up at 6 months or biopsy based on patient preference and risk.
• ACR BI-RADS 4 or 5: core needle biopsy, breast surgery referral.
• Imaging negative but discharge persists: MRI breast and/or ductoscopy referral.

Step 5. Act on serum prolactin result.

• Prolactin <25 ng/mL with normal TSH: physiologic; reassure.
• Prolactin 25-200 ng/mL: repeat fasting morning level; if confirmed, order pituitary MRI with gadolinium.
• Prolactin >200 ng/mL: order pituitary MRI immediately; initiate cabergoline after neurosurgery or endocrinology consultation.

What to Expect at Your Appointment

Bring a list of all current medications, including supplements and hormonal contraceptives. Wear a two-piece outfit so the breast exam is straightforward. The clinician will ask about your menstrual pattern, any recent pregnancy or breastfeeding, and whether you have experienced headaches or vision changes.

The visit itself takes 20-30 minutes. Blood draws, if ordered, require a follow-up of 3-5 business days for results. Imaging ordered the same day is typically read by a radiologist within 24-48 hours in most outpatient breast centers.